Current management of chemotherapy-induced neutropenia in adults: key points and new challengesYi Ba, Chenfei Zhou, Yuankai Shi et al.|Cancer Biology and Medicine|2020Cited by 95
Efficacy and safety of geptanolimab (GB226) for relapsed or refractory peripheral T cell lymphoma: an open-label phase 2 study (Gxplore-002)Yuankai Shi, Qian Wang, Ye Guo et al.|Journal of Hematology & Oncology|2021Cited by 64
Comparison of efficacy and safety of ripertamab (SCT400) versus rituximab (Mabthera <sup>®</sup> ) in combination with CHOP in patients with previously untreated CD20‐positive diffuse large B‐cell lymphoma: A randomized, single‐blind, phase III clinical trialYuankai Shi, Yanan Ji, Qingyuan Zhang et al.|Hematological Oncology|2022Cited by 9
Brentuximab vedotin in treating Chinese patients with lymphoma: A multicenter, real‐world studyXudong Zhang, Mingzhi Zhang, Honghan Qiao et al.|Cancer Medicine|2023Cited by 4
Combination of Mitoxantrone Hydrochloride Liposome with Cyclophosphamide, Vincristine and Prednisone (CMOP) in Treatment-Naïve Patients with Peripheral T-Cell Lymphoma: A Multicenter, Open-Label, Single-Arm, Phase Ib Clinical TrialHuiqiang Huang, Peng Wang, Ming Jiang et al.|Blood|2022Cited by 3